Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications
Vaccination against SARS-CoV-2 has rapidly expanded, however clinical trials excluded patients taking immunosuppressive medications such as those with inflammatory bowel disease (IBD). Therefore, we explored real-world effectiveness of COVID-19 vaccination on subsequent infection in IBD patients with diverse exposure to immunosuppressive medications.
Source: Gastroenterology - Category: Gastroenterology Authors: Nabeel Khan, Nadim Mahmud Source Type: research
More News: Clinical Trials | COVID-19 | Gastroenterology | Inflammatory Bowel Disease | SARS | Vaccines